Extracellular matrix protein βig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation

  1. Chaoyu Ma1,
  2. Yu Rong1,
  3. Daniel R. Radiloff1,
  4. Michael B. Datto2,
  5. Barbara Centeno3,
  6. Shideng Bao4,
  7. Anthony Wai Ming Cheng2,
  8. Fumin Lin1,
  9. Shibo Jiang5,
  10. Timothy J. Yeatman3, and
  11. Xiao-Fan Wang1,6
  1. 1 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA;
  2. 2 Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA;
  3. 3 Department of Surgery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA;
  4. 4 Department of Radiation Oncology and Department of Neurosurgery, University of Colorado at Denver and Health Science Center, Aurora, Colorado 80045, USA;
  5. 5 Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York 10021, USA

Abstract

Metastasis, the major cause of cancer death, is a multistep process that requires interactions between cancer cells and stromal cells and between cancer cells and extracellular matrix. Molecular alterations of the extracellular matrix in the tumor microenvironment have a considerable impact on the metastatic process during tumorigenesis. Here we report that elevated expression of βig-h3/TGFBI (transforming growth factor, β-induced), an extracellular matrix protein secreted by colon cancer cells, is associated with high-grade human colon cancers. Ectopic expression of the βig-h3 protein enhanced the aggressiveness and altered the metastatic properties of colon cancer cells in vivo. Inhibition of βig-h3 expression dramatically reduced metastasis. Mechanistically, βig-h3 appears to promote extravasation, a critical step in the metastatic dissemination of cancer cells, by inducing the dissociation of VE-cadherin junctions between endothelial cells via activation of the integrin αvβ5–Src signaling pathway. Thus, cancers associated with overexpression of βig-h3 may have an increased metastatic potential, leading to poor prognosis in cancer patients.

Keywords

Footnotes

| Table of Contents

Life Science Alliance